Skip to main content
Clinical Trials/NCT04697329
NCT04697329
Completed
Phase 4

Laparoscopic Cholecystectomy: Use of Infiltration With Levobupivacaine and Postoperative Pain: A Randomized Controlled Trial

Hospital Universitario de Móstoles1 site in 1 country233 target enrollmentDecember 3, 2020

Overview

Phase
Phase 4
Intervention
Preincisional infiltration with levobupivacaine
Conditions
Laparoscopic Cholecystectomy
Sponsor
Hospital Universitario de Móstoles
Enrollment
233
Locations
1
Primary Endpoint
Postoperative pain assessed by visual numeric scale.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Randomized controlled trial on laparoscopic cholecystectomy. Interventional group: preincisional infiltration with levobupivacaine. Control group: no local infiltration.

Postoperative pain with numeric rating scale is registered, besides other parameters like heart rate, blood pressure, rescue analgesia requirements, nausea and vomiting, etc.

Registry
clinicaltrials.gov
Start Date
December 3, 2020
End Date
May 26, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hospital Universitario de Móstoles
Responsible Party
Principal Investigator
Principal Investigator

JORGE HERRADOR BENITO

Principal Investigator. Surgeon.

Hospital Universitario de Móstoles

Eligibility Criteria

Inclusion Criteria

  • Elective laparoscopic cholecystectomy

Exclusion Criteria

  • Patient refusal
  • Open surgery
  • Reintervention surgery
  • Drain tube placement
  • Cognitive impairment
  • Allergic reactions to local anesthetics

Arms & Interventions

Local infiltration

Intervention: Preincisional infiltration with levobupivacaine

Outcomes

Primary Outcomes

Postoperative pain assessed by visual numeric scale.

Time Frame: 24 hours

Values come from 0 to 10, where 0 means no pain and 10 means the worst imaginable pain. Best outcome would be 0 or close to 0

Secondary Outcomes

  • Postoperative administration of analgesics(24 hours)
  • Postoperative nausea and vomiting episodes(24 hours)

Study Sites (1)

Loading locations...

Similar Trials